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Abstract 35 
Background: Dysregulated homeostatic response to stressors may underlie frailty in older 36 
adults. Orthostatic hypotension results from impairments in cardiovascular homeostasis and 37 
is implicated in falls and other adverse outcomes. This study aimed to characterise the 38 
relationships between orthostatic BP and heart rate recovery and frailty in an older 39 
population. 40 
Design: Cross-sectional study 41 
Setting: Two health centres in the Republic of Ireland 42 
Participants: 4334 adults aged 50 and older enrolled in The Irish Longitudinal Study on 43 
Ageing 44 
Measurements: Continuous non-invasive blood pressure (BP) responses during active 45 
standing were captured by Finometer
®
. Frailty was assessed using the Cardiovascular Health 46 
Study criteria. Linear mixed models (random intercept) with piecewise splines were used to 47 
model differences in the rate of BP and heart rate recovery. 48 
Results: 93 (2.2%) participants were frail and 1366 (31.5%) were prefrail. Adjusting for age 49 
and sex, frailty was associated with a reduced rate of systolic BP recovery between 10-20 50 
seconds post stand (frailty*time = -4.12 95%CI: -5.53 - -2.72) and with subsequent deficits in 51 
BP between 20-50 seconds. Similar results were seen for diastolic BP and heart rate. Further 52 
adjustment for health behaviours, morbidities, and medications reduced, but did not 53 
attenuate these associations. Of the 5 frailty criteria, only slow gait speed was consistently 54 
related to impaired BP and heart rate responses in the full models. 55 
Conclusions: Frailty, and particularly slow gait speed, was associated with reduced rate of 56 
recovery in BP and heart rate recovery following active standing. Impaired BP recovery may 57 
represent a marker of physiological frailty. 58 
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Impact statement 67 
We certify that this work is novel or confirmatory of recent novel clinical research. The 68 
potential impact of this research on clinical care or health policy includes the following: it 69 
highlights the relevance of impaired blood pressure regulation as a potential cause of 70 
adverse outcomes in older adults with signs of frailty, with implications for decision making 71 
around antihypertensive treatment. The results also show that slow gait speed captures 72 
physiological frailty at least was well as the overall phenotype criteria. More broadly, they 73 
tentatively suggest rate of recovery in blood pressure immediately post standing may be a 74 
useful way to assess physiological reserve in older adults. 75 
 76 
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Introduction 87 
Levels of functional ability and risk of adverse health outcomes vary widely across older 88 
adults. This differential vulnerability among adults of the same age is often referred to as 89 
frailty.
1, 2
 Frailty can be conceptualised as a syndrome of physiological dysregulation leading 90 
to a decreased ability to respond to homeostatic stressors, and recognisable as a phenotype 91 
comprising 5 related criteria: slow gait, muscle weakness, poor endurance or exhaustion, 92 
low physical activity and loss of (lean) body weight.
3
  93 
Few studies have directly explored the relationships between this frailty phenotype and 94 
dynamic measures of homeostatic responses. Orthostasis, or standing up, is a mild 95 
physiological stressor requiring an integrative neuro-cardiovascular response to maintain 96 
blood pressure (BP) homeostasis in the face of large shifts in blood volume distribution.
4
 97 
Impaired responses can lead to excessive falls in BP known as orthostatic hypotension (OH). 98 
In analogy to frailty, OH may reflect various underlying health deficits and is predictive of 99 
adverse outcomes in older adults.
5, 6
  100 
In previous studies OH, defined according to the consensus definition of a sustained drop of 101 
20mmHg in systolic BP (SBP) or 10mmHg in diastolic BP (DBP) 
7
, was not related to physical 102 
frailty.
8, 9
 However, frailty has been associated with lower heart rate (HR) variability, another 103 
sign of impaired autonomic control of the cardiovascular system, in older women.
10, 11
  104 
Discrete BP measurements capture only a fraction of the full hemodynamic responses. 105 
Studies using continuous BP monitoring suggest aging is characterised by a gradual slowing 106 
of initial BP recovery post-standing, indicative of declining BP homeostatic function.
12
 107 
Recent data has linked impairments in early BP recovery to mortality in older falls clinic 108 
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patients.
13
  Similarly, pilot data from a convenience sample of older Irish adults suggested 109 
possible relationships between orthostatic hemodynamics and frailty.
14
   110 
We hypothesise the frailty phenotype and impaired orthostatic hemodynamics to be shared 111 
manifestations of an underlying physiological frailty. In addition, there may be direct 112 
mechanisms linking the physical frailty criteria to BP homeostasis, including loss of muscle 113 
mass and strength, impaired peripheral nerve function and/or declining central nervous co-114 
ordination.
14
  115 
This study aimed to characterise the BP and HR responses to orthostasis across levels of 116 
frailty within a large population sample of middle-aged to older adults and to assess the role 117 
of health conditions and medications in these relationships. We further aimed to explore 118 
the relationships between hemodynamic responses and the different frailty criteria. 119 
 120 
 121 
 122 
 123 
 124 
 125 
 126 
 127 
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Methods 129 
Sample 130 
The Irish Longitudinal Study on Ageing (TILDA) includes 8175 participants representative of 131 
the community living population aged ≥50 in Ireland.  Households were selected in 132 
geographic clusters from a list of all residential addresses in Ireland.  Each selected 133 
household was visited by an interviewer and any resident aged ≥50 as well as their spouse 134 
or partner were invited to participate. The household response rate was 62.0%. Each 135 
participant provided written informed consent.  Those with severe cognitive impairment 136 
preventing meaningful consent were not included in the study. Approval for the study was 137 
obtained from the Trinity College Faculty of Health Sciences Research Ethics Committee.  138 
 139 
Participants underwent a structured interview in their homes covering their health, lifestyle, 140 
social and financial circumstances.  5035 participants agreed to attend for a comprehensive 141 
health center assessment. The sampling procedure and health assessment have been 142 
described in detail previously.
15
  Measures specific to the current analysis are detailed 143 
below. 144 
 145 
Frailty 146 
Frailty was assessed using an adaptation of the frailty phenotype.
3
 The detailed methods 147 
used are reported elsewhere.
16
 Briefly, the criteria were: 148 
Slowness: The sex specific slowest 20% gait speed from participants aged ≥65 stratified by 149 
height, based on 16ft walk time. Cut-points were 109.7cm/s for men shorter than 173cm 150 
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and 116.7cm/s for men taller than 173cm.  For women, they were 100.7cm/s for those 151 
shorter than 159cm and 108.4cm/s for those taller than 159cm. 152 
Weakness: The sex specific lowest 20% grip strength from participants aged ≥65 stratified by 153 
body mass index (BMI). Cut-points were 20.5kg for men with BMI<24, 21.5kg for men with 154 
BMI of 24-26, and 23kg for men with BMI >26.  For women, they were 11.5kg for those with 155 
BMI<23 and 13kg for those with BMI>23 156 
Low Activity: The sex specific lowest 20% energy expenditure from participants aged ≥65, 157 
based on the International Physical Activity Questionnaire (IPAQ). Cut-points were <868 158 
kcal/week for men and <309 kcal/week for women. 159 
Exhaustion: Responding ‘sometimes’ or ‘often’ to the Centre for Epidemiological Studies 160 
Depression scale (CES-D) items “I could not get going” or “I felt that everything I did was an 161 
effort”  162 
Weight loss: Self-reporting unintentionally losing ≥10lbs in weight in the last year.  163 
Active stand protocol 164 
Participants underwent a lying-to-standing orthostatic test (active stand) with non-invasive 165 
continuous beat-to-beat BP monitoring using digital photoplethysmography (Finometer
®
 166 
MIDI device, Finapres Medical Systems BV, Amsterdam, The Netherlands, 167 
www.finapres.com). After ten minutes’ supine rest participants were asked to stand in a 168 
timely manner (<5 seconds) and were aided by a research nurse when necessary. After 169 
standing, SBP, DBP and HR were monitored for three minutes of quiet standing. The 170 
instrument calibration, data processing and feature extraction for this test have been 171 
described in detail previously.
12, 17, 18
  172 
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 173 
For analysis, beat-to-beat values were averaged according to the 5-second averages method 174 
to filter any noise.
19
 Features were then extracted from each record. The algorithm captures 175 
BP and HR values at 10-second intervals up to 110 seconds post stand using the 5-second 176 
averages for each time-point. In addition, the lowest BP values (nadirs) and highest HR 177 
(maximum) are recorded. Baseline was defined as the mean value from 60-30 seconds prior 178 
to standing. From this data additional parameters were calculated, specifically the 179 
percentage of baseline recovered at each time-point and the maximum change (delta) in BP 180 
and HR during standing. 181 
 182 
Other measures 183 
Height and weight were measured using standard procedures and BMI defined as weight 184 
(kg) divided by height
2
 (m). Participants reported doctor diagnoses of any cardiovascular 185 
conditions and gave a list of medications. Participants were also asked about health 186 
behaviors including smoking. Depressive symptoms were assessed using the 20-item CES-187 
D,
20
 the two items used in the frailty definition were excluded from analyses.  188 
 189 
Statistical Analysis 190 
Statistical analyses were performed in Stata version 14.2. Differences across frailty groups 191 
were assessed using Analysis of Variance (ANOVA) for normally distributed continuous 192 
variables, Kruskil-Wallis tests for non-normally distributed variables and Chi-squared tests 193 
for categorical variables.  194 
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Linear mixed effects models (Stata’s ‘mixed’ command) with a participant level random 195 
intercept were used to model the recovery in BP or heart rate from 10-110 seconds post 196 
stand, comparable to modelling change over time in a longitudinal analysis.
21, 22
 The primary 197 
outcome measure was the percentage of BP or heart rate recovered over the time standing. 198 
Residual variance across time was modelled using an autoregressive correlation matrix with 199 
a lag of 1 to account for stronger correlations between closer together time-points. 200 
Conceptually, the recovery of BP and heart rate can be broken down into an initial rapid 201 
recovery phase followed by a stabilisation and ‘levelling off’ towards the baseline. 202 
Consequently, we parameterised time using linear splines with knots at 20 and 30 seconds 203 
with the slopes between these knots representing the different phases of the stand (10s-204 
20s, 20s-30s, 30s-110s).
21
 These re-parameterized time variables were included in the 205 
models as fixed effects. 206 
Main effects and interactions with the time variables were included for all predictors. The 207 
interaction term between frailty and time represents the effect of frailty on the rate of 208 
recovery with time in each period, that is to what extent frailty determines the slope of 209 
recovery over that time. To aid interpretation we additionally present conditional mean 210 
responses during the stand, ie the expected values of BP or HR recovery (% of baseline) 211 
across frailty groups over time holding all covariates constant at their means. The basic 212 
models included age (as linear and quadratic terms to account for the potential non-linear 213 
relationship) and sex. The full models additionally included fixed between-patient effects for 214 
BMI (linear and quadratic), smoking, antihypertensive (ATC codes C02 and C07) and 215 
antidepressant medications, depressive symptoms and self-reported cardiovascular 216 
conditions; hypertension, diabetes, stroke, heart attack, angina and heart murmur. 217 
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Relationships with the individual frailty criteria were modelled using the same approach. 218 
The full model outputs are provided in supplemental appendix tables 1-7. 219 
 220 
 221 
 222 
 223 
 224 
 225 
 226 
 227 
 228 
 229 
 230 
 231 
 232 
 233 
 234 
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Results 236 
Data on frailty and orthostatic BP responses were available for 4334 participants from the 237 
health center sample, with a mean (SD) age of 61.6 (8.2) years (Table 1). 2327 (53.7%) were 238 
female, 2674 (61.7%) had ≥1 cardiovascular conditions and 638 (14.7%) were current 239 
smokers (Table 1). 93 (2.2%) participants were frail and 1366 (31.51 %) prefrail. Frailer 240 
participants had higher BMI and depressive symptoms and levels of current smoking and 241 
medication use (all p<0.001).  242 
The overall resting mean (SD) SBP was 136.2 (22.3) mmHg, DBP 73.3 (11.2) mmHg and HR 243 
65.2 (10.1) beats per minute (bpm) (Table 1). There was a trend towards higher baseline SBP 244 
across the frailty groups, while baseline DBP was lower (Table 1). Baseline HR was higher in 245 
frail participants; 67.6 (10.3), compared to 64.7 (9.7) in robust (p <0.001). The maximum 246 
drop in SBP and DBP was similar across groups, while the maximum increase in HR was 247 
smaller in frail participants, 18.8 (8.2) compared to 20.1 (8.7) (p=0.011) in robust.  248 
Table 1 shows the coefficients for the relationships between frailty category and rate of 249 
recovery for each phase of the stand for % baseline BP or heart rate recovered. Conditional 250 
values from the models are shown in Figure 1. After controlling for age and sex, frailty was 251 
associated a slower recovery rate between 10-20 seconds after standing in both SBP (-252 
4.12%/sec 95%CI=-5.53, -2.72 in frail compared to robust; -0.99 (-1.37,-0.60) for prefrail) 253 
and DBP (frail: -5.26 (-6.87,-3.65); prefrail: -1.80 (-2.24,-1.36)). Correspondingly, frailty was 254 
associated with deficits of approximately 3-4% in SBP and DBP over the following 40 255 
seconds (20-60 seconds post standing, Figure 1 & Table S1). DBP was actually higher at 10 256 
seconds suggestive of a more gradual pattern of drop and recovery (Fig 1).  There was little 257 
difference in the rate of recovery between 20-30 seconds, but frailty was associated with a 258 
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steeper slope from 30-110 seconds for SBP recovery, as BP continued to recover over this 259 
time in frailer people. The general patterns of results were similar using the BP values in 260 
mmHG at each time point, rather than the percentage of baseline as the outcome variables 261 
(Supplemental Table 2 and Figure 1). The models also suggested residual variance was 262 
higher in frailer people, especially for SBP (Appendix tables 1 & 2). 263 
Further adjustment for BMI, smoking, depressive symptoms, cardiovascular conditions and 264 
medications partially reduced the differences in the initial recovery slopes in SBP and DBP 265 
(Table 2). Although much of the relationship remained, the associated deficits in SBP and 266 
DBP were reduced to 1-2% lower in frail compared to robust (Figure 1). 267 
HR was higher throughout standing in the frail and prefrail groups compared to robust 268 
reflecting the higher baseline (Supplemental Fig 1). In the main analysis, heart rate 269 
effectively mirrored the BP responses with a slower rate of decrease in heart rate (between 270 
10-20 seconds) (Table 2). Heart rate was then slightly higher relative to baseline at 20 271 
seconds with the difference between groups diminishing over the rest of the stand. As with 272 
BP further adjustment partially attenuated the slope from 10 seconds, although differences 273 
between groups at 20 seconds remained similar as adjustment also reduced the lower peak 274 
heart rate at 10 seconds.  275 
After adjustment for all covariates and the other frailty criteria, slow gait speed was 276 
associated with slower rate of recovery in BP and heart rate between 10-20 seconds (Table 277 
3), and with deficits in SBP and to a lesser extent DBP throughout the following 40 seconds 278 
post standing (Figure 2). Slow gait was also associated with lower peak heart rate and higher 279 
values at 20 seconds post stand.  Weight loss was associated with mild deficits in DBP 280 
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recovery. Exhaustion was associated with reduced recovery rate for SBP and heart rate, but 281 
not clearly with deficits at any time point (Table 3).  282 
 283 
 284 
 285 
 286 
 287 
 288 
 289 
 290 
 291 
 292 
 293 
 294 
 295 
 296 
 297 
 298 
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Discussion  299 
Frailty was associated with slower BP and heart rate recovery following standing in this 300 
sample of community dwelling middle-aged to older adults. In general less than half the 301 
effect was explained by adjustment for health behaviours, morbidities and medication use. 302 
When considered separately only slow gait speed was consistently related to impaired SBP 303 
and to a lesser extent DBP and HR responses independently of cardiovascular morbidities, 304 
medication use and the other frailty criteria.  305 
Frailty has been associated with (sub)clinical cardiovascular disease and with impaired 306 
autonomic cardiovascular control.
11, 23
 However, previous analyses from TILDA and the 307 
Canadian Study of Health and Aging have not shown clear relationships between OH and 308 
physical frailty.
8, 9
 The conventional OH measurement used in these studies is based on 309 
discrete measurements which do not detect the early transient BP responses. An earlier 310 
beat-to-beat monitoring study found univariate trends towards impaired SBP recovery in 311 
frailer participants in a convenience sample of older adults.
14
 The present study extends 312 
these findings using more sophisticated statistical methods to better characterise BP 313 
behaviour within a larger sample drawn from a population representative survey. 314 
An increasingly detailed theoretical framework links frailty or resilience to an individual’s 315 
capacity to resist stressors.
1, 24, 25,26
 However, direct support is lacking, with the best 316 
evidence so far coming from impaired response to Oral Glucose Tolerance test in frail older 317 
women.
27
 The reduced BP recovery rate associated with frailty in this study provides some 318 
further support for this hypothesis. 319 
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The general pattern in frailer participants was a blunted early response in both BP and heart 320 
rate consistent with poorer autonomic compensation mechanisms following the stress of 321 
standing, and associated with deficits of 3-4% in BP over 30-40 seconds during the 1
st
 322 
minute post stand. It is worth noting the relatively modest size of these differences across 323 
groups and their functional significance is not yet clear. The small mean deficits may also 324 
reflect the relatively large variance across frail participants. 325 
Recent findings of excess mortality in older falls patients experiencing impaired early BP 326 
recovery post standing, suggest transient deficits or later stabilisation of BP may be a 327 
marker of underlying physiological impairment.
13
 Similarly, elevated resting heart rate is 328 
associated with increased mortality rates and may reflect low physical fitness and subclinical 329 
cardiovascular disease.
28, 29
 Previous data from TILDA outlined an association between 330 
slower orthostatic heart rate recovery and increased 4-year mortality risk.
22
 These 331 
hemodynamic differences could also contribute directly to adverse outcomes like falls in 332 
frail older adults. Analyses from TILDA found increased 2-year falls risk associated with 333 
delayed or incomplete BP recovery.
30
 In another study, greater drops in BP and higher 334 
resting heart rate were associated with increased risk of low energy fractures (suggestive of 335 
injurious falls) over 25 years.
31
   336 
Adjustment for morbidities, health behaviours and medications only partially attenuated the 337 
differences in BP recovery rates, although deficits between frail and robust groups were 338 
reduced to 1-2%. The interpretation of this is unclear, it may be that impaired BP responses 339 
reflect both an intrinsic physiological frailty and the burden of associated health deficits.
32
   340 
Of the 5 frailty criteria, only slow gait speed was consistently related to poorer BP and heart 341 
rate recovery in fully adjusted models. Slower gait is strongly related to subsequent health 342 
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outcomes in older adults and has been suggested as a measure of frailty in its own right.
33, 34
 343 
The lack of consistent association with the other criteria indirectly suggests slow gait may 344 
actually be a more useful measure of physiological frailty than the frailty phenotype 345 
composite.   346 
There may also be specific mechanisms linking slower gait speed and impaired orthostatic 347 
BP responses. OH has been associated with poorer peripheral motor nerve function in older 348 
adults.
35
 It has also been associated with increased burden of White Matter Hyperintensities 349 
(WMH) on Magnetic Resonance Imaging scans, thought to reflect cerebral small vessel 350 
disease, in late life depression.
36
 A number of cross-sectional and longitudinal studies have 351 
linked these brain changes to mobility decline.
37-40
  352 
The immediate clinical implications of these findings are that poorer orthostatic BP 353 
regulation should be considered as a possible cause of falls in frailer older adults before 354 
instigating more intensive BP control as in the SPRINT trial.
41
 More broadly they suggest a 355 
single mobility test provides sufficient information on physiological frailty to aid clinical 356 
decision making. Work from TILDA increasingly indicates the rate of recovery in BP and 357 
heart rate to be more informative than the size of initial drops in older adults.
22, 30
 And, if 358 
validated further, non-invasive measures of BP homeostasis could provide a quick and 359 
effective means to assess physiological reserve.    360 
Strengths of this study include the high quality assessments of frailty and orthostatic 361 
responses within this large sample and the breadth of data collected on potential 362 
confounding variables. The mixed modelling approach used provides a useful summary of 363 
the BP responses, but further work is needed to more completely model variation in the 364 
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shape of responses, identify the most meaningful parameters and optimally account for 365 
varying correlations between time-points. 366 
The study also has some general limitations. It was not possible to control for factors that 367 
influence BP such as feeding or hydration status, although these factors did not affect BP 368 
behavior in a sub-study.
42
 The mean age of the sample was 61.6 years and participants 369 
attending the health assessment were generally healthier than those who declined, limiting 370 
the prevalence of frailty. Despite the large overall sample the relatively small number of frail 371 
participants may have limited statistical power as well as the generalizability of the findings 372 
within the relatively young Irish population. The comparative healthiness of the sample may 373 
partially explain the modest size of effects. The cross-sectional design precludes 374 
determination of the causal direction of relationships. Findings were based on almost 375 
exclusively Caucasian Irish adults and should be extrapolated beyond this setting with care.  376 
In summary, physical frailty, and especially slow gait speed, is associated with impairments 377 
in early orthostatic BP and HR recovery in older adults. Future studies to further establish 378 
the utility of orthostatic hemodynamics as measures of physiological frailty and their 379 
relationship to mobility decline are warranted.    380 
 381 
 382 
 383 
 384 
 385 
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Table 1: Participant characteristics 
 
Overall Robust Prefrail Frail P 
  n=4334 n=2875 n=1366 n=93   
Age (mean (SD)) 61.6 (8.2) 60.5 (7.6) 63.4 (8.9) 68.0 (11.2) 
<0.001
a
 
Female (count (%)) 2327 (53.7) 1537 (53.5) 738 (54.0) 52 (55.9) 0.86
b
 
BMI (mean (SD)) 28.5 (4.9) 28.2 (4.7) 29.1 (5.0) 29.3 (7.0) 
<0.001
a
 
Depressive symptoms (median 
(IQR)) 3 (1 - 7) 3 (0 - 5) 5 (1 - 10) 10 (5 - 20) 
<0.001
c
 
Current smoker (count (%)) 638 (14.7) 379 (13.2) 234 (17.1) 25 (26.9) 
<0.001
a
 
Any CVD condition (count (%)) 2674 (61.7) 1678 (58.4) 924 (67.6) 72 (77.4) 
<0.001
a
 
On antihypertensives (count (%)) 568 (13.2) 316 (11.0) 236 (17.4) 16 (17.8) 
<0.001
a
 
On antidepressants (count (%)) 256 (5.9) 108 (3.8) 125 (9.2) 23 (25.6) 
<0.001
a
 
            
Baseline systolic BP (mean (SD)) 
136.2 
(22.3) 
135.8 
(21.7) 
136.9 
(23.2) 
138.6 
(25.5) 0.15
a
 
Max ∆ systolic BP (mean (SD)) 
-39.3 
(17.9) 
-39.0 
(17.4) 
-39.8 
(18.7) 
-41.6 
(19.3) 0.17
a
 
            
Baseline diastolic BP (mean (SD)) 73.3 (11.2) 73.6 (11.0) 72.7 (11.6) 71.4 (11.2) 0.016
a
 
Max ∆ diastolic BP (mean (SD)) 
-25.8 
(10.3) 
-25.9 
(10.1) 
-25.8 
(10.8) 
-25.0 
(10.8) 0.74
a
 
            
Baseline heart rate (mean (SD)) 65.2 (10.1) 64.7 (9.7) 66.1 (10.7) 67.6 (10.3) 
<0.001
a
 
Max ∆ heart rate (mean (SD)) 19.8 (8.9) 20.1 (8.7) 19.3 (9.2) 18.8 (8.2) 0.011
a
 
a
ANOVA
 b
Chi-square
 c
Kruskil-Wallis 
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Table 2: Model parameters for blood pressure and heart rate recovery following active standing (% 
recovery) 
 
Frailty*Time (rate of recovery) 
  
Intercept (10s 
difference) 10-20s 20-30s 30-110s 
Systolic BP         
Model 1         
Prefrail 0.39 [-0.41,1.20] 
-0.99 [-1.37,-
0.60]*** 0.01 [-0.38,0.39] 
0.15 
[0.06,0.25]** 
Frail 0.29 [-2.58,3.17] 
-4.12 [-5.53,-
2.72]*** 
-0.25 [-
1.65,1.15] 0.46 [0.10,0.82]* 
Model 2 
    
Prefrail 0.44 [-0.40,1.28] 
-0.88 [-1.29,-
0.47]*** 0.07 [-0.34,0.48] 0.10 [-0.00,0.20] 
Frail 1.07 [-1.97,4.10] 
-2.71 [-4.21,-
1.21]*** 
-0.29 [-
1.79,1.21] 0.27 [-0.12,0.66] 
Diastolic BP 
    Model 1 
    
Prefrail 0.80 [-0.01,1.61] 
-1.80 [-2.24,-
1.36]*** 
-0.18 [-
0.62,0.26] 
0.15 
[0.05,0.24]** 
Frail 2.77 [0.10,5.44]* 
-5.26 [-6.87,-
3.65]*** 
-1.17 [-
2.77,0.42] 0.25 [-0.07,0.58] 
Model 2 
    
Prefrail 0.55 [-0.31,1.40] 
-1.39 [-1.86,-
0.92]*** 0.07 [-0.40,0.53] 0.10 [-0.00,0.20] 
Frail 2.59 [-0.27,5.45] 
-3.44 [-5.16,-
1.71]*** 
-0.76 [-
2.47,0.95] 0.09 [-0.26,0.44] 
Heart rate 
    Model 1 
    
Prefrail -1.26 [-1.93,-0.59]*** 1.74 [1.36,2.13]*** 
-0.03 [-
0.41,0.35] -0.06 [-0.14,0.01] 
Frail -2.02 [-4.20,0.16] 4.92 [3.73,6.11]*** 
-1.10 [-
2.29,0.08] -0.24 [-0.49,0.01] 
Model 2 
    Prefrail -0.51 [-1.22,0.19] 1.22 [0.81,1.62]*** 0.07 [-0.33,0.47] -0.03 [-0.11,0.05] 
Frail 0.70 [-1.64,3.03] 2.41 [1.12,3.70]*** 
-1.12 [-
2.40,0.16] -0.17 [-0.45,0.10] 
Parameters are estimated from mixed effects models with linear splines. Interaction coefficients represent the 
difference in slopes or rate of recovery in blood pressure or heart rate at each stage of the active stand. Model 
1: Age and sex, Model 2: Age, sex, BMI, smoking, depressive symptoms, self-reported CVD conditions, 
medication use *P<0.05, **P<0.01, ***P<0.001 
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Table 3: Model parameters for the relationships between frailty criteria and blood pressure and 
heart rate recovery (% baseline) 
  
Frailty*Time (rate of recovery) 
  
Intercept (10s 
difference) 10-20s 20-30s 30-110s 
Systolic BP         
Slowness -0.72 [-2.12,0.68] 
-2.33 [-3.02,-
1.64]*** 0.96 [0.27,1.65]** 
0.22 
[0.06,0.39]** 
Activity 0.69 [-0.36,1.73] -0.48 [-0.99,0.04] -0.45 [-0.96,0.06] 0.06 [-0.06,0.18] 
Grip 0.09 [-1.23,1.40] -0.41 [-1.05,0.24] 0.56 [-0.09,1.20] 0.05 [-0.11,0.20] 
Exhaustion 1.12 [-0.38,2.63] -0.76 [-1.50,-0.02]* 
-0.89 [-1.63,-
0.16]* 0.11 [-0.07,0.29] 
Weight loss 0.24 [-1.29,1.77] -0.61 [-1.37,0.14] -0.74 [-1.49,0.01] 0.03 [-0.15,0.21] 
Diastolic BP         
Slowness 1.89 [0.45,3.32]** 
-3.82 [-4.59,-
3.04]*** 0.70 [-0.07,1.47] 0.11 [-0.05,0.27] 
Activity 0.64 [-0.43,1.71] -0.56 [-1.14,0.02] 
-0.64 [-1.21,-
0.06]* 0.05 [-0.07,0.17] 
Grip -0.22 [-1.57,1.12] -0.26 [-0.98,0.47] 0.66 [-0.07,1.38] 0.01 [-0.15,0.16] 
Exhaustion 0.73 [-0.81,2.27] -0.62 [-1.45,0.22] -0.70 [-1.53,0.13] 0.12 [-0.05,0.30] 
Weight loss 0.30 [-1.27,1.87] -1.11 [-1.96,-0.26]* 
-0.92 [-1.76,-
0.07]* 0.05 [-0.13,0.23] 
Heart rate         
Slowness -1.76 [-2.96,-0.55]** 3.26 [2.57,3.96]*** 0.47 [-0.26,1.21] -0.10 [-0.23,0.04] 
Activity 0.26 [-0.63,1.16] 0.21 [-0.30,0.73] 0.15 [-0.60,0.90] 0.02 [-0.08,0.12] 
Grip 0.29 [-0.84,1.41] 0.53 [-0.12,1.18] -0.10 [-0.23,0.04] -0.02 [-0.15,0.11] 
Exhaustion -0.64 [-1.93,0.65] 1.20 [0.46,1.95]** 0.02 [-0.08,0.12] -0.09 [-0.24,0.06] 
Weight loss 0.16 [-1.15,1.47] 0.05 [-0.71,0.80] -0.02 [-0.15,0.11] -0.01 [-0.16,0.14] 
Parameters are estimated from mixed effects models with linear splines. Interaction coefficients represent the 
difference in slopes or rate of recovery in blood pressure or heart rate at each stage of the active stand. 
*P<0.05, **P<0.01, ***P<0.001 
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Figure legends: 
 
Figure 1: Adjusted blood pressure and heart rate responses across frailty categories 
Data are adjusted conditional means and 95% confidence intervals estimated from mixed 
effects models. Model 1: Age and sex; Model 2: age, sex, BMI, smoking, antihypertensive 
and antidepressant medication use, depressive symptoms and CVD conditions, and are 
mutually adjusted for the presence of the other frailty criteria 
 
Figure 2: Conditional differences in percentage blood pressure recovery according to the 
presence of each frailty criterion 
Differences are relative to the reference not having the criterion. All models include age, 
sex, BMI, smoking, antihypertensive and antidepressant medication use, depressive 
symptoms and CVD conditions, and are mutually adjusted for the presence of the other 
frailty criteria.  
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Supplemental data 
Table S1: Conditional differences in blood pressure or heart rate recovery compared to robust 
category in % recovered 
SBP         
 
Model 1 
 
Model 2 
  Prefrail Frail Prefrail Frail 
10 0.39 [-0.41,1.20] 0.29 [-2.58,3.17] 0.44 [-0.40,1.28] 1.07 [-1.97,4.10] 
20 -0.59 [-1.39,0.21] -3.83 [-6.69,-0.97]** -0.44 [-1.28,0.40] -1.65 [-4.67,1.38] 
30 -0.59 [-1.38,0.21] -4.08 [-6.92,-1.23]** -0.37 [-1.20,0.46] -1.93 [-4.94,1.07] 
40 -0.44 [-1.19,0.32] -3.62 [-6.30,-0.94]** -0.27 [-1.06,0.52] -1.67 [-4.49,1.16] 
50 -0.28 [-1.00,0.44] -3.16 [-5.71,-0.61]* -0.17 [-0.92,0.59] -1.40 [-4.09,1.29] 
60 -0.13 [-0.83,0.57] -2.70 [-5.17,-0.23]* -0.07 [-0.80,0.67] -1.13 [-3.73,1.48] 
70 0.02 [-0.67,0.71] -2.24 [-4.69,0.21] 0.04 [-0.69,0.76] -0.86 [-3.44,1.72] 
80 0.17 [-0.53,0.87] -1.78 [-4.25,0.69] 0.14 [-0.60,0.87] -0.59 [-3.20,2.02] 
90 0.32 [-0.40,1.04] -1.32 [-3.87,1.23] 0.24 [-0.52,0.99] -0.32 [-3.01,2.37] 
100 0.48 [-0.28,1.23] -0.86 [-3.54,1.82] 0.34 [-0.45,1.13] -0.05 [-2.88,2.77] 
110 0.63 [-0.17,1.42] -0.40 [-3.25,2.44] 0.44 [-0.39,1.27] 0.22 [-2.79,3.22] 
DBP         
10 0.80 [-0.01,1.61] 2.77 [0.10,5.44]* 0.55 [-0.31,1.40] 2.59 [-0.27,5.45] 
20 -1.00 [-1.80,-0.20]* -2.49 [-5.13,0.15] -0.84 [-1.69,0.00] -0.84 [-3.68,1.99] 
30 -1.18 [-1.97,-0.39]** -3.66 [-6.23,-1.09]** -0.77 [-1.61,0.06] -1.61 [-4.36,1.15] 
40 -1.03 [-1.78,-0.28]** -3.41 [-5.84,-0.98]** -0.68 [-1.47,0.11] -1.52 [-4.11,1.08] 
50 -0.88 [-1.60,-0.16]* -3.16 [-5.47,-0.84]** -0.58 [-1.34,0.18] -1.43 [-3.90,1.05] 
60 -0.73 [-1.43,-0.03]* -2.90 [-5.15,-0.65]* -0.48 [-1.22,0.25] -1.34 [-3.74,1.06] 
70 -0.58 [-1.27,0.11] -2.65 [-4.88,-0.42]* -0.38 [-1.11,0.35] -1.25 [-3.62,1.13] 
80 -0.43 [-1.13,0.27] -2.40 [-4.64,-0.15]* -0.29 [-1.02,0.45] -1.16 [-3.56,1.25] 
90 -0.28 [-1.00,0.43] -2.14 [-4.46,0.17] -0.19 [-0.94,0.57] -1.06 [-3.54,1.41] 
100 -0.13 [-0.88,0.61] -1.89 [-4.32,0.54] -0.09 [-0.88,0.70] -0.97 [-3.57,1.62] 
110 0.01 [-0.77,0.80] -1.64 [-4.21,0.93] 0.01 [-0.82,0.84] -0.88 [-3.64,1.87] 
HR         
10 -1.26 [-1.93,-0.59]*** -2.02 [-4.20,0.16] -0.51 [-1.22,0.19] 0.70 [-1.64,3.03] 
20 0.49 [-0.17,1.15] 2.90 [0.74,5.06]** 0.70 [0.01,1.40]* 3.10 [0.79,5.42]** 
30 0.46 [-0.19,1.10] 1.80 [-0.32,3.92] 0.77 [0.10,1.45]* 1.98 [-0.29,4.25] 
40 0.39 [-0.22,1.01] 1.56 [-0.45,3.57] 0.74 [0.10,1.39]* 1.80 [-0.35,3.96] 
50 0.33 [-0.26,0.92] 1.32 [-0.61,3.25] 0.71 [0.10,1.33]* 1.63 [-0.43,3.69] 
60 0.26 [-0.31,0.84] 1.08 [-0.79,2.96] 0.68 [0.08,1.28]* 1.45 [-0.55,3.46] 
70 0.20 [-0.37,0.77] 0.85 [-1.02,2.71] 0.65 [0.06,1.25]* 1.28 [-0.70,3.26] 
80 0.13 [-0.44,0.71] 0.61 [-1.27,2.48] 0.62 [0.02,1.22]* 1.10 [-0.90,3.11] 
90 0.07 [-0.52,0.66] 0.37 [-1.56,2.30] 0.59 [-0.03,1.21] 0.93 [-1.13,2.99] 
100 0.00 [-0.61,0.62] 0.13 [-1.88,2.14] 0.56 [-0.08,1.20] 0.76 [-1.40,2.91] 
110 -0.06 [-0.71,0.59] -0.11 [-2.23,2.01] 0.53 [-0.15,1.21] 0.58 [-1.69,2.85] 
Parameters are estimated from mixed effects models with linear splines. Model 1: Age and sex, 
Model 2: Age, sex, BMI, smoking, depressive symptoms, self-reported CVD conditions, medication 
use *P<0.05, **P<0.01, ***P<0.001 
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Table S2: Model parameters for Blood pressure and heart rate recovery following active standing (Actual values) 
  
Frailty*Time (rate of recovery) 
  Intercept (10s difference) 10-20s 20-30s 30-110s 
Systolic BP (mmHg)         
Model 1         
Prefrail 0.34 [-1.30,1.98] -1.27 [-1.78,-0.75]*** -0.04 [-0.55,0.47] 0.20 [0.07,0.33]** 
Frail 1.27 [-4.66,7.21] -5.99 [-7.89,-4.09]*** -0.47 [-2.37,1.43] 0.67 [0.13,1.21]* 
Model 2 
 Prefrail 0.13 [-1.59,1.85] -1.20 [-1.74,-0.66]*** 0.08 [-0.46,0.62] 0.13 [-0.01,0.27] 
Frail 0.89 [-5.39,7.17] -4.47 [-6.49,-2.44]*** -0.46 [-2.49,1.57] 0.43 [-0.14,1.01] 
Diastolic BP (mmHg)         
Model 1         
Prefrail 0.10 [-0.74,0.94] -1.30 [-1.60,-0.99]*** -0.25 [-0.55,0.05] 0.10 [0.04,0.16]** 
Frail 1.01 [-1.76,3.78] -3.87 [-4.99,-2.75]*** -0.93 [-2.03,0.18] 0.20 [-0.03,0.43] 
Model 2 
 Prefrail -0.08 [-0.95,0.80] -1.01 [-1.33,-0.69]*** -0.04 [-0.36,0.28] 0.07 [0.00,0.13]* 
Frail 0.32 [-2.59,3.23] -2.80 [-4.00,-1.60]*** -0.61 [-1.80,0.58] 0.10 [-0.15,0.35] 
Heart rate (HR)         
Model 1         
Prefrail 0.92 [0.18,1.67]* 1.03 [0.78,1.29]*** -0.04 [-0.29,0.21] -0.04 [-0.09,0.01] 
Frail 2.09 [-0.32,4.50] 2.99 [2.22,3.76]*** -0.78 [-1.55,-0.01]* -0.14 [-0.30,0.02] 
Model 2 
 Prefrail 0.98 [0.22,1.74]* 0.71 [0.44,0.98]*** 0.04 [-0.23,0.30] -0.02 [-0.07,0.03] 
Frail 1.42 [-1.05,3.90] 1.45 [0.61,2.29]*** -0.73 [-1.56,0.10] -0.11 [-0.29,0.07] 
Parameters are estimated from mixed effects models with linear splines. Interaction coefficients represent the difference in time slopes or rate of recovery in blood 
pressure or heart rate at each stage of the active stand. Model 1: Age and sex, Model 2: Age, sex, BMI, smoking, depressive symptoms, self-reported CVD conditions, 
medication use*P<0.05, **P<0.01, ***P<0.001 
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Table S3: Conditional differences in blood pressure or heart rate recovery compared to robust 
category in mmHg or beats per minute 
SBP         
 
Model 1 Model 2 
  Prefrail Frail Prefrail Frail 
10 0.34 [-1.30,1.98] 1.27 [-4.66,7.21] 0.13 [-1.59,1.85] 0.89 [-5.39,7.17] 
20 -0.93 [-2.56,0.71] -4.72 [-10.65,1.21] -1.07 [-2.78,0.64] -3.57 [-9.85,2.70] 
30 -0.97 [-2.60,0.66] -5.19 [-11.11,0.74] -0.99 [-2.69,0.72] -4.03 [-10.30,2.24] 
40 -0.77 [-2.36,0.83] -4.52 [-10.27,1.23] -0.86 [-2.53,0.81] -3.60 [-9.68,2.48] 
50 -0.57 [-2.14,1.00] -3.85 [-9.47,1.78] -0.73 [-2.37,0.92] -3.17 [-9.11,2.78] 
60 -0.37 [-1.92,1.18] -3.18 [-8.72,2.37] -0.60 [-2.22,1.03] -2.73 [-8.59,3.12] 
70 -0.17 [-1.72,1.37] -2.51 [-8.02,3.01] -0.47 [-2.09,1.15] -2.30 [-8.13,3.53] 
80 0.03 [-1.53,1.58] -1.84 [-7.38,3.71] -0.34 [-1.96,1.29] -1.87 [-7.73,3.99] 
90 0.23 [-1.34,1.79] -1.17 [-6.79,4.46] -0.21 [-1.85,1.43] -1.44 [-7.38,4.51] 
100 0.42 [-1.17,2.02] -0.50 [-6.25,5.25] -0.08 [-1.75,1.59] -1.00 [-7.08,5.08] 
110 0.62 [-1.01,2.25] 0.17 [-5.75,6.10] 0.05 [-1.66,1.76] -0.57 [-6.84,5.70] 
DBP         
10 0.10 [-0.74,0.94] 1.01 [-1.76,3.78] -0.08 [-0.95,0.80] 0.32 [-2.59,3.23] 
20 -1.20 [-2.04,-0.37]** -2.86 [-5.62,-0.10]* -1.08 [-1.96,-0.21]* -2.48 [-5.38,0.42] 
30 -1.45 [-2.28,-0.62]*** -3.79 [-6.52,-1.06]** -1.13 [-1.99,-0.27]* -3.09 [-5.96,-0.22]* 
40 -1.35 [-2.16,-0.54]** -3.59 [-6.25,-0.93]** -1.06 [-1.91,-0.22]* -2.99 [-5.78,-0.20]* 
50 -1.25 [-2.05,-0.45]** -3.39 [-6.00,-0.78]* -0.99 [-1.83,-0.16]* -2.90 [-5.63,-0.16]* 
60 -1.15 [-1.94,-0.36]** -3.19 [-5.76,-0.61]* -0.93 [-1.75,-0.10]* -2.80 [-5.50,-0.10]* 
70 -1.05 [-1.83,-0.26]** -2.99 [-5.55,-0.42]* -0.86 [-1.68,-0.04]* -2.70 [-5.39,-0.01]* 
80 -0.94 [-1.74,-0.15]* -2.79 [-5.36,-0.21]* -0.79 [-1.62,0.03] -2.60 [-5.30,0.10] 
90 -0.84 [-1.64,-0.05]* -2.59 [-5.20,0.02] -0.73 [-1.56,0.11] -2.51 [-5.24,0.23] 
100 -0.74 [-1.55,0.07] -2.39 [-5.05,0.27] -0.66 [-1.50,0.19] -2.41 [-5.20,0.38] 
110 -0.64 [-1.47,0.19] -2.19 [-4.92,0.54] -0.59 [-1.45,0.27] -2.31 [-5.18,0.56] 
HR         
10 0.92 [0.18,1.67]* 2.09 [-0.32,4.50] 0.98 [0.22,1.74]* 1.42 [-1.05,3.90] 
20 1.96 [1.21,2.70]*** 5.08 [2.68,7.48]*** 1.69 [0.94,2.45]*** 2.87 [0.40,5.34]* 
30 1.92 [1.18,2.65]*** 4.30 [1.91,6.69]*** 1.73 [0.98,2.48]*** 2.15 [-0.30,4.60] 
40 1.88 [1.16,2.60]*** 4.16 [1.81,6.51]*** 1.71 [0.98,2.45]*** 2.04 [-0.37,4.44] 
50 1.84 [1.13,2.56]*** 4.02 [1.70,6.34]*** 1.70 [0.97,2.42]*** 1.93 [-0.45,4.30] 
60 1.81 [1.10,2.52]*** 3.88 [1.58,6.18]*** 1.68 [0.96,2.40]*** 1.82 [-0.54,4.17] 
70 1.77 [1.06,2.48]*** 3.74 [1.44,6.03]** 1.66 [0.94,2.38]*** 1.71 [-0.64,4.06] 
80 1.73 [1.02,2.44]*** 3.59 [1.29,5.89]** 1.65 [0.93,2.37]*** 1.60 [-0.75,3.95] 
90 1.70 [0.98,2.41]*** 3.45 [1.13,5.77]** 1.63 [0.91,2.36]*** 1.49 [-0.88,3.86] 
100 1.66 [0.94,2.39]*** 3.31 [0.96,5.66]** 1.62 [0.88,2.35]*** 1.38 [-1.02,3.79] 
110 1.63 [0.89,2.36]*** 3.17 [0.78,5.56]** 1.60 [0.85,2.35]*** 1.27 [-1.18,3.72] 
Parameters are estimated from mixed effects models with linear splines. Model 1: Age and sex, Model 2: Age, 
sex, BMI, smoking, depressive symptoms, self-reported CVD conditions, medication use *P<0.05, **P<0.01, 
***P<0.001 
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Figure S1: Adjusted blood pressure and heart rate responses across frailty categories 
Data are adjusted conditional means and 95% confidence intervals estimated from mixed 
effects models. Model 1: Age and sex; Model 2: age, sex, BMI, smoking, antihypertensive 
and antidepressant medication use, depressive symptoms and CVD conditions, and are 
mutually adjusted for the presence of the other frailty criteria 
                Robust                       Prefrail                       Frail 
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Appendix Tables – Full model outputs 
Table SA1: Mixed effects models for % SBP recovery 
Main effects Model 1 Model 2 
Period 1 10-20s 1.71 (-7.43 - 10.84) -16.56 (-26.41 - -6.71) 
Period 2 20-30s -4.07 (-13.18 - 5.04) 2.02 (-7.81 - 11.85) 
Period 3 30-110s -1.61 (-3.81 - 0.59) -0.43 (-2.80 - 1.95) 
Prefrail 0.39 (-0.41 - 1.20) 0.44 (-0.40 - 1.28) 
Frail 0.29 (-2.58 - 3.17) 1.07 (-1.97 - 4.10) 
Age -0.42 (-1.01 - 0.17) -0.52 (-1.11 - 0.07) 
Age*age 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 
Female -1.56 (-2.27 - -0.85) -1.14 (-1.88 - -0.40) 
Antidepressant 
 
-3.84 (-5.44 - -2.25) 
Antihypertensive 
 
-3.05 (-4.24 - -1.86) 
BMI 
 
0.77 (0.29 - 1.24) 
BMI*BMI 
 
-0.01 (-0.02 - 0.00) 
Past smoker 
 
0.50 (-0.28 - 1.27) 
Current smoker 
 
-0.10 (-1.18 - 0.98) 
CES-D score 
 
-0.01 (-0.07 - 0.06) 
Diabetes 
 
1.51 (-0.01 - 3.03) 
Stroke 
 
-2.25 (-5.86 - 1.35) 
Angina 
 
-2.77 (-4.71 - -0.83) 
Heart attack 
 
1.42 (-0.60 - 3.43) 
Hypertension 
 
1.17 (0.35 - 2.00) 
Heart murmur 
 
-0.31 (-1.94 - 1.32) 
Interactions 10-20s    
Prefrail*time -0.99 (-1.37 - -0.60) -0.88 (-1.29 - -0.47) 
Frail*time -4.12 (-5.53 - -2.72) -2.71 (-4.21 - -1.21) 
Age*time 0.81 (0.52 - 1.10) 0.89 (0.59 - 1.18) 
Age*age*time -0.01 (-0.01 - -0.01) -0.01 (-0.01 - -0.01) 
Female*time -2.01 (-2.36 - -1.67) -1.60 (-1.96 - -1.23) 
Antidepressant*time 
 
-0.62 (-1.40 - 0.16) 
Antihypertensive*time 
 
0.02 (-0.57 - 0.61) 
BMI*time 
 
0.98 (0.75 - 1.22) 
BMI*BMI*time 
 
-0.01 (-0.02 - -0.01) 
Past smoker*time 
 
-0.51 (-0.89 - -0.13) 
Current smoker*time 
 
-2.03 (-2.56 - -1.50) 
CES-D score*time 
 
-0.03 (-0.06 - 0.00) 
Diabetes*time 
 
-0.62 (-1.37 - 0.13) 
Stroke*time 
 
1.01 (-0.75 - 2.76) 
Angina*time 
 
1.42 (0.47 - 2.37) 
Heart attack*time 
 
1.05 (0.06 - 2.04) 
Hypertension*time 
 
-2.12 (-2.53 - -1.72) 
Heart murmur*time 
 
0.92 (0.11 - 1.72) 
Interactions 20-30s    
Prefrail*time 0.01 (-0.38 - 0.39) 0.07 (-0.34 - 0.48) 
Frail*time -0.25 (-1.65 - 1.15) -0.29 (-1.79 - 1.21) 
Age*time 0.05 (-0.24 - 0.33) 0.00 (-0.30 - 0.29) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 1.68 (1.34 - 2.03) 1.56 (1.20 - 1.92) 
Antidepressant*time 
 
0.92 (0.14 - 1.69) 
Antihypertensive*time 
 
0.86 (0.27 - 1.44) 
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BMI*time 
 
-0.19 (-0.42 - 0.05) 
BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
-0.21 (-0.59 - 0.17) 
Current smoker*time 
 
0.45 (-0.08 - 0.98) 
CES-D score*time 
 
-0.02 (-0.05 - 0.01) 
Diabetes*time 
 
-1.10 (-1.85 - -0.36) 
Stroke*time 
 
0.73 (-1.03 - 2.48) 
Angina*time 
 
0.74 (-0.20 - 1.69) 
Heart attack*time 
 
-0.50 (-1.49 - 0.49) 
Hypertension*time 
 
0.74 (0.33 - 1.15) 
Heart murmur*time 
 
0.20 (-0.60 - 1.00) 
Interactions 30-110s    
Prefrail*time 0.15 (0.06 - 0.25) 0.10 (0.00 - 0.20) 
Frail*time 0.46 (0.10 - 0.82) 0.27 (-0.12 - 0.66) 
Age*time 0.02 (-0.05 - 0.09) 0.02 (-0.05 - 0.09) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 0.06 (-0.02 - 0.14) 0.04 (-0.05 - 0.12) 
Antidepressant*time 
 
0.16 (-0.03 - 0.35) 
Antihypertensive*time 
 
0.01 (-0.13 - 0.16) 
BMI*time 
 
-0.08 (-0.13 - -0.02) 
BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
0.03 (-0.06 - 0.13) 
Current smoker*time 
 
0.19 (0.06 - 0.32) 
CES-D score*time 
 
0.01 (0.00 - 0.01) 
Diabetes*time 
 
0.13 (-0.05 - 0.31) 
Stroke*time 
 
-0.11 (-0.55 - 0.33) 
Angina*time 
 
0.13 (-0.10 - 0.36) 
Heart attack*time 
 
-0.01 (-0.25 - 0.23) 
Hypertension*time 
 
0.07 (-0.03 - 0.17) 
Heart murmur*time 
 
0.12 (-0.07 - 0.31) 
     
Intercept 95.91 (77.18 - 114.63) 83.24 (63.23 - 103.25) 
Random effects (identity matrix)     
Intercept variance 71.96 (67.17 - 77.09) 67.87 (63.18 - 72.92) 
AR1 Residuals by Frailty category     
variance     
Robust 61.68 (58.53 - 64.98) 61.49 (58.31 - 64.84) 
Prefrail 89.55 (82.26 - 97.49) 90.61 (83.17 - 98.72) 
Frail 120.38 (90.48 - 160.17) 124.69 (92.53 - 168.02) 
rho     
Robust 0.74 (0.72 - 0.75) 0.74 (0.73 - 0.75) 
Prefrail 0.80 (0.78 - 0.81) 0.80 (0.78 - 0.82) 
Frail 0.81 (0.75 - 0.86) 0.81 (0.75 - 0.86) 
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Table SA2: Mixed effects models for % DBP recovery 
Main effects Model 1 Model 2 
Period 1 10-20s 12.04 (1.71 - 22.37) 3.03 (-8.12 - 14.17) 
Period 2 20-30s -3.84 (-14.10 - 6.41) 3.82 (-7.24 - 14.89) 
Period 3 30-110s -1.16 (-3.32 - 0.99) -0.35 (-2.68 - 1.97) 
Prefrail 0.80 (-0.01 - 1.61) 0.55 (-0.31 - 1.40) 
Frail 2.77 (0.10 - 5.44) 2.59 (-0.27 - 5.45) 
Age -0.62 (-1.21 - -0.02) -0.72 (-1.32 - -0.12) 
Age*age 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 
Female 0.34 (-0.38 - 1.06) 0.68 (-0.07 - 1.44) 
Antidepressant 
 
-2.35 (-3.97 - -0.73) 
Antihypertensive 
 
-2.87 (-4.08 - -1.65) 
BMI 
 
0.90 (0.42 - 1.39) 
BMI*BMI 
 
-0.01 (-0.02 - 0.00) 
Past smoker 
 
0.46 (-0.33 - 1.26) 
Current smoker 
 
0.76 (-0.35 - 1.87) 
CES-D score 
 
0.03 (-0.03 - 0.10) 
Diabetes 
 
1.26 (-0.29 - 2.81) 
Stroke 
 
-3.08 (-6.71 - 0.54) 
Angina 
 
-3.67 (-5.64 - -1.70) 
Heart attack 
 
0.54 (-1.52 - 2.59) 
Hypertension 
 
1.32 (0.47 - 2.17) 
Heart murmur 
 
-1.25 (-2.92 - 0.42) 
Interactions 10-20s   
Prefrail*time -1.80 (-2.24 - -1.36) -1.39 (-1.86 - -0.92) 
Frail*time -5.26 (-6.87 - -3.65) -3.44 (-5.16 - -1.71) 
Age*time 0.63 (0.30 - 0.96) 0.80 (0.48 - 1.13) 
Age*age*time -0.01 (-0.01 - -0.01) -0.01 (-0.01 - -0.01) 
Female*time -3.18 (-3.58 - -2.79) -3.08 (-3.50 - -2.67) 
Antidepressant*time -0.18 (-1.06 - 0.71) 
Antihypertensive*time 0.15 (-0.51 - 0.81) 
BMI*time 
 
0.41 (0.15 - 0.68) 
BMI*BMI*time 
 
-0.01 (-0.01 - 0.00) 
Past smoker*time 
 
-0.96 (-1.39 - -0.53) 
Current smoker*time -2.02 (-2.63 - -1.42) 
CES-D score*time 
 
-0.06 (-0.09 - -0.02) 
Diabetes*time 
 
-1.57 (-2.42 - -0.72) 
Stroke*time 
 
3.00 (1.00 - 5.01) 
Angina*time 
 
1.68 (0.61 - 2.76) 
Heart attack*time 
 
2.33 (1.21 - 3.45) 
Hypertension*time -2.30 (-2.76 - -1.84) 
Heart murmur*time -0.51 (-1.42 - 0.39) 
Interactions 20-30s   
Prefrail*time -0.18 (-0.62 - 0.26) 0.07 (-0.40 - 0.53) 
Frail*time -1.17 (-2.77 - 0.42) -0.76 (-2.47 - 0.95) 
Age*time 0.13 (-0.19 - 0.45) 0.10 (-0.22 - 0.43) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 2.81 (2.43 - 3.20) 2.65 (2.24 - 3.06) 
Antidepressant*time 0.09 (-0.79 - 0.97) 
Antihypertensive*time 0.83 (0.17 - 1.49) 
BMI*time 
 
-0.27 (-0.53 - -0.01) 
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BMI*BMI*time 
 
0.00 (0.00 - 0.01) 
Past smoker*time 
 
-0.33 (-0.76 - 0.10) 
Current smoker*time -0.53 (-1.12 - 0.07) 
CES-D score*time 
 
-0.02 (-0.06 - 0.02) 
Diabetes*time 
 
-1.31 (-2.15 - -0.47) 
Stroke*time 
 
0.00 (-1.99 - 1.99) 
Angina*time 
 
1.19 (0.12 - 2.26) 
Heart attack*time 
 
-0.62 (-1.73 - 0.50) 
Hypertension*time 0.73 (0.27 - 1.18) 
Heart murmur*time 
 
0.36 (-0.54 - 1.26) 
Interactions 30-110s   
Prefrail*time 0.15 (0.05 - 0.24) 0.10 (0.00 - 0.20) 
Frail*time 0.25 (-0.07 - 0.58) 0.09 (-0.26 - 0.44) 
Age*time 0.01 (-0.05 - 0.08) 0.01 (-0.06 - 0.08) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 0.08 (0.00 - 0.16) 0.06 (-0.03 - 0.15) 
Antidepressant*time 0.11 (-0.08 - 0.30) 
Antihypertensive*time 0.05 (-0.09 - 0.19) 
BMI*time 
 
-0.05 (-0.11 - 0.00) 
BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
0.05 (-0.04 - 0.14) 
Current smoker*time 0.12 (0.00 - 0.25) 
CES-D score*time 
 
0.01 (0.00 - 0.02) 
Diabetes*time 
 
0.12 (-0.06 - 0.30) 
Stroke*time 
 
-0.20 (-0.62 - 0.23) 
Angina*time 
 
0.06 (-0.17 - 0.29) 
Heart attack*time 
 
-0.08 (-0.32 - 0.15) 
Hypertension*time 0.04 (-0.06 - 0.13) 
Heart murmur*time 
 
0.20 (0.01 - 0.39) 
     
Intercept 96.75 (77.80 - 115.71) 80.22 (59.81 - 100.62) 
Random effects (identity matrix)   
Intercept variance 83.37 (78.87 - 88.13) 82.05 (77.58 - 86.79) 
AR1 Residuals by Frailty category   
variance     
Robust 58.03 (55.80 - 60.36) 57.52 (55.29 - 59.83) 
Prefrail 78.61 (73.63 - 83.92) 77.20 (72.26 - 82.48) 
Frail 81.71 (66.37 - 100.59) 85.43 (68.54 - 106.48) 
rho     
Robust 0.65 (0.64 - 0.66) 0.65 (0.64 - 0.66) 
Prefrail 0.69 (0.67 - 0.71) 0.69 (0.67 - 0.71) 
Frail 0.63 (0.54 - 0.70) 0.63 (0.54 - 0.71) 
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Table SA3: Mixed effects models for % HR recovery 
Main effects Model 1 Model 2 
Period 1 10-20s -69.39 (-78.50 - -60.28) -44.75 (-54.57 - -34.92) 
Period 2 20-30s 28.21 (19.19 - 37.23) 28.81 (19.09 - 38.53) 
Period 3 30-110s 1.67 (-0.16 - 3.50) 2.25 (0.30 - 4.21) 
Prefrail -1.26 (-1.93 - -0.59) -0.51 (-1.22 - 0.19) 
Frail -2.02 (-4.20 - 0.16) 0.70 (-1.64 - 3.03) 
Age -0.68 (-1.18 - -0.17) -0.52 (-1.03 - -0.02) 
Age*age 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 
Female -1.17 (-1.78 - -0.56) -1.25 (-1.89 - -0.61) 
Antidepressant 
 
-3.53 (-4.88 - -2.18) 
Antihypertensive 
 
-2.52 (-3.54 - -1.50) 
BMI 
 
0.77 (0.36 - 1.18) 
BMI*BMI 
 
-0.01 (-0.02 - 0.00) 
Past smoker 
 
0.00 (-0.67 - 0.67) 
Current smoker 
 
-2.80 (-3.73 - -1.87) 
CES-D score 
 
0.00 (-0.05 - 0.06) 
Diabetes 
 
-3.31 (-4.60 - -2.02) 
Stroke 
 
-0.31 (-3.29 - 2.67) 
Angina 
 
-1.35 (-2.99 - 0.29) 
Heart attack 
 
-0.98 (-2.69 - 0.73) 
Hypertension 
 
-2.14 (-2.85 - -1.42) 
Heart murmur 
 
0.48 (-0.92 - 1.89) 
Interactions 10-20s    
Prefrail*time 1.74 (1.36 - 2.13) 1.22 (0.81 - 1.62) 
Frail*time 4.92 (3.73 - 6.11) 2.41 (1.12 - 3.70) 
Age*time 1.45 (1.16 - 1.73) 1.38 (1.09 - 1.67) 
Age*age*time -0.01 (-0.01 - -0.01) -0.01 (-0.01 - 0.00) 
Female*time -0.64 (-0.98 - -0.29) -0.91 (-1.27 - -0.54) 
Antidepressant*time 
 
2.49 (1.72 - 3.27) 
Antihypertensive*time -0.17 (-0.76 - 0.42) 
BMI*time 
 
-1.53 (-1.76 - -1.29) 
BMI*BMI*time 
 
0.02 (0.02 - 0.03) 
Past smoker*time 
 
0.48 (0.09 - 0.86) 
Current smoker*time 3.86 (3.32 - 4.39) 
CES-D score*time 
 
0.02 (-0.01 - 0.05) 
Diabetes*time 
 
1.67 (0.92 - 2.41) 
Stroke*time 
 
0.43 (-1.29 - 2.15) 
Angina*time 
 
1.32 (0.37 - 2.26) 
Heart attack*time 
 
0.94 (-0.05 - 1.93) 
Hypertension*time 
 
1.79 (1.38 - 2.20) 
Heart murmur*time 
 
-0.50 (-1.31 - 0.31) 
Interactions 20-30s    
Prefrail*time -0.03 (-0.41 - 0.35) 0.07 (-0.33 - 0.47) 
Frail*time -1.10 (-2.29 - 0.08) -1.12 (-2.40 - 0.16) 
Age*time -0.90 (-1.19 - -0.62) -0.89 (-1.18 - -0.61) 
Age*age*time 0.01 (0.00 - 0.01) 0.01 (0.00 - 0.01) 
Female*time 0.27 (-0.08 - 0.61) 0.24 (-0.13 - 0.60) 
Antidepressant*time 
 
0.39 (-0.38 - 1.15) 
Antihypertensive*time 0.32 (-0.26 - 0.90) 
BMI*time 
 
0.00 (-0.23 - 0.24) 
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BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
-0.03 (-0.41 - 0.35) 
Current smoker*time 0.18 (-0.35 - 0.71) 
CES-D score*time 
 
-0.02 (-0.05 - 0.01) 
Diabetes*time 
 
0.72 (-0.02 - 1.46) 
Stroke*time 
 
0.17 (-1.53 - 1.88) 
Angina*time 
 
-1.07 (-2.01 - -0.13) 
Heart attack*time 
 
-0.02 (-1.00 - 0.95) 
Hypertension*time 
 
-0.16 (-0.57 - 0.25) 
Heart murmur*time 
 
-0.82 (-1.62 - -0.02) 
Interactions 30-110s    
Prefrail*time -0.06 (-0.14 - 0.01) -0.03 (-0.11 - 0.05) 
Frail*time -0.24 (-0.49 - 0.01) -0.17 (-0.45 - 0.10) 
Age*time -0.02 (-0.08 - 0.03) -0.01 (-0.07 - 0.05) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 0.06 (-0.01 - 0.13) 0.02 (-0.05 - 0.10) 
Antidepressant*time 
 
0.01 (-0.14 - 0.17) 
Antihypertensive*time -0.10 (-0.21 - 0.02) 
BMI*time 
 
-0.04 (-0.09 - 0.00) 
BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
-0.04 (-0.11 - 0.04) 
Current smoker*time -0.11 (-0.22 - -0.01) 
CES-D score*time 
 
0.00 (-0.01 - 0.01) 
Diabetes*time 
 
-0.08 (-0.22 - 0.07) 
Stroke*time 
 
0.12 (-0.22 - 0.46) 
Angina*time 
 
-0.04 (-0.23 - 0.15) 
Heart attack*time 
 
0.09 (-0.11 - 0.28) 
Hypertension*time 
 
-0.05 (-0.13 - 0.03) 
Heart murmur*time 
 
-0.03 (-0.19 - 0.13) 
     
Intercept 
157.26 (141.30 - 
173.22) 
140.17 (123.09 - 
157.26) 
Random effects (identity matrix)   
Intercept variance 58.73 (55.59 - 62.06) 57.37 (54.29 - 60.62) 
AR1 Residuals by Frailty category   
variance     
Robust 46.94 (45.15 - 48.80) 45.25 (43.56 - 47.01) 
Prefrail 47.74 (45.23 - 50.38) 46.34 (43.93 - 48.89) 
Frail 50.39 (40.40 - 62.85) 53.21 (41.96 - 67.48) 
rho     
Robust 0.64 (0.62 - 0.65) 0.63 (0.61 - 0.64) 
Prefrail 0.63 (0.61 - 0.65) 0.62 (0.60 - 0.64) 
Frail 0.68 (0.60 - 0.75) 0.69 (0.60 - 0.76) 
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Table SA4: Mixed effects models for SBP recovery 
Main effects Model 1 Model 2 
Period 1 10-20s -15.43 (-27.53 - -3.32) -40.89 (-53.94 - -27.84) 
Period 2 20-30s -6.85 (-18.93 - 5.23) -0.21 (-13.24 - 12.81) 
Period 3 30-110s -1.10 (-4.03 - 1.83) 0.26 (-2.91 - 3.43) 
Prefrail 0.34 (-1.30 - 1.98) 0.13 (-1.59 - 1.85) 
Frail 1.27 (-4.66 - 7.21) 0.89 (-5.39 - 7.17) 
Age 1.37 (0.15 - 2.60) 0.97 (-0.25 - 2.19) 
Age*age -0.01 (-0.02 - 0.00) -0.01 (-0.01 - 0.00) 
Female 0.63 (-0.84 - 2.10) 0.56 (-0.97 - 2.09) 
Antidepressant 
 
-3.46 (-6.74 - -0.18) 
Antihypertensive 
 
-5.89 (-8.35 - -3.42) 
BMI 
 
1.68 (0.70 - 2.67) 
BMI*BMI 
 
-0.02 (-0.04 - -0.01) 
Past smoker 
 
-0.80 (-2.41 - 0.80) 
Current smoker 
 
-2.80 (-5.05 - -0.56) 
CES-D score 
 
0.12 (-0.01 - 0.26) 
Diabetes 
 
0.66 (-2.48 - 3.79) 
Stroke 
 
-3.23 (-10.58 - 4.12) 
Angina 
 
-6.88 (-10.87 - -2.90) 
Heart attack 
 
-2.29 (-6.45 - 1.86) 
Hypertension 
 
5.43 (3.71 - 7.15) 
Heart murmur 
 
-2.75 (-6.13 - 0.63) 
Interactions 10-20s    
Prefrail*time -1.27 (-1.78 - -0.75) -1.20 (-1.74 - -0.66) 
Frail*time -5.99 (-7.89 - -4.09) -4.47 (-6.49 - -2.44) 
Age*time 1.57 (1.19 - 1.95) 1.59 (1.21 - 1.98) 
Age*age*time -0.01 (-0.02 - -0.01) -0.01 (-0.02 - -0.01) 
Female*time -2.26 (-2.72 - -1.80) -1.77 (-2.25 - -1.29) 
Antidepressant*time 
 
-0.30 (-1.33 - 0.74) 
Antihypertensive*time 
 
-0.20 (-0.98 - 0.57) 
BMI*time 
 
1.50 (1.19 - 1.81) 
BMI*BMI*time 
 
-0.02 (-0.03 - -0.02) 
Past smoker*time 
 
-0.85 (-1.36 - -0.35) 
Current smoker*time 
 
-3.21 (-3.91 - -2.50) 
CES-D score*time 
 
-0.02 (-0.06 - 0.02) 
Diabetes*time 
 
-1.09 (-2.08 - -0.10) 
Stroke*time 
 
0.29 (-2.04 - 2.61) 
Angina*time 
 
1.29 (0.04 - 2.55) 
Heart attack*time 
 
0.52 (-0.79 - 1.83) 
Hypertension*time 
 
-1.92 (-2.46 - -1.38) 
Heart murmur*time 
 
1.18 (0.12 - 2.25) 
Interactions 20-30s    
Prefrail*time -0.04 (-0.55 - 0.47) 0.08 (-0.46 - 0.62) 
Frail*time -0.47 (-2.37 - 1.43) -0.46 (-2.49 - 1.57) 
Age*time 0.10 (-0.28 - 0.48) 0.03 (-0.36 - 0.41) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 2.35 (1.89 - 2.81) 2.19 (1.70 - 2.67) 
Antidepressant*time 
 
1.33 (0.30 - 2.36) 
Antihypertensive*time 
 
1.11 (0.34 - 1.89) 
BMI*time 
 
-0.14 (-0.45 - 0.17) 
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BMI*BMI*time 
 
0.00 (-0.01 - 0.00) 
Past smoker*time 
 
-0.26 (-0.76 - 0.24) 
Current smoker*time 
 
0.44 (-0.27 - 1.14) 
CES-D score*time 
 
-0.02 (-0.07 - 0.02) 
Diabetes*time 
 
-1.58 (-2.56 - -0.59) 
Stroke*time 
 
0.90 (-1.42 - 3.22) 
Angina*time 
 
0.79 (-0.47 - 2.04) 
Heart attack*time 
 
-1.15 (-2.46 - 0.15) 
Hypertension*time 
 
1.11 (0.57 - 1.65) 
Heart murmur*time 
 
0.19 (-0.87 - 1.25) 
Interactions 30-110s    
Prefrail*time 0.20 (0.07 - 0.33) 0.13 (-0.01 - 0.27) 
Frail*time 0.67 (0.13 - 1.21) 0.43 (-0.14 - 1.01) 
Age*time -0.01 (-0.10 - 0.09) -0.01 (-0.10 - 0.08) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 0.09 (-0.02 - 0.20) 0.06 (-0.06 - 0.17) 
Antidepressant*time 
 
0.20 (-0.06 - 0.45) 
Antihypertensive*time 
 
0.03 (-0.15 - 0.22) 
BMI*time 
 
-0.09 (-0.17 - -0.02) 
BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
0.04 (-0.08 - 0.16) 
Current smoker*time 
 
0.27 (0.10 - 0.44) 
CES-D score*time 
 
0.01 (0.00 - 0.02) 
Diabetes*time 
 
0.15 (-0.10 - 0.39) 
Stroke*time 
 
-0.05 (-0.64 - 0.53) 
Angina*time 
 
0.14 (-0.16 - 0.45) 
Heart attack*time 
 
-0.03 (-0.35 - 0.29) 
Hypertension*time 
 
0.07 (-0.06 - 0.20) 
Heart murmur*time 
 
0.15 (-0.11 - 0.41) 
     
Intercept 56.08 (17.29 - 94.88) 37.26 (-4.15 - 78.67) 
Random effects (identity matrix)     
Intercept variance 484.80 (461.61 - 509.15) 464.58 (441.81 - 488.53) 
AR1 Residuals by Frailty category     
variance     
Robust 107.04 (101.53 - 112.84) 106.44 (100.90 - 112.30) 
Prefrail 162.61 (146.42 - 180.58) 167.18 (149.73 - 186.68) 
Frail 329.37 (180.59 - 600.72) 352.45 (181.23 - 685.46) 
rho     
Robust 0.74 (0.72 - 0.75) 0.74 (0.72 - 0.75) 
Prefrail 0.80 (0.78 - 0.82) 0.81 (0.79 - 0.83) 
Frail 0.87 (0.77 - 0.93) 0.88 (0.77 - 0.94) 
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Table SA5: Mixed effects models for DBP recovery 
Main effects Model 1 Model 2 
Period 1 10-20s 8.44 (1.24 - 15.63) 2.40 (-5.36 - 10.16) 
Period 2 20-30s -3.33 (-10.46 - 3.80) 1.81 (-5.88 - 9.51) 
Period 3 30-110s -0.74 (-2.21 - 0.73) -0.30 (-1.88 - 1.28) 
Prefrail 0.10 (-0.74 - 0.94) -0.08 (-0.95 - 0.80) 
Frail 1.01 (-1.76 - 3.78) 0.32 (-2.59 - 3.23) 
Age -0.17 (-0.80 - 0.46) -0.35 (-0.98 - 0.27) 
Age*age 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 
Female -1.25 (-2.01 - -0.49) -1.41 (-2.20 - -0.62) 
Antidepressant 
 
-0.61 (-2.28 - 1.06) 
Antihypertensive 
 
-4.19 (-5.45 - -2.92) 
BMI 
 
0.84 (0.34 - 1.34) 
BMI*BMI 
 
-0.01 (-0.02 - 0.00) 
Past smoker 
 
-0.22 (-1.04 - 0.61) 
Current smoker 
 
-0.62 (-1.77 - 0.53) 
CES-D score 
 
0.07 (0.00 - 0.14) 
Diabetes 
 
-0.79 (-2.39 - 0.81) 
Stroke 
 
-1.90 (-5.61 - 1.81) 
Angina 
 
-4.03 (-6.07 - -1.99) 
Heart attack 
 
-2.59 (-4.71 - -0.46) 
Hypertension 
 
2.39 (1.51 - 3.28) 
Heart murmur 
 
-2.26 (-4.00 - -0.53) 
Interactions 10-20s    
Prefrail*time -1.30 (-1.60 - -0.99) -1.01 (-1.33 - -0.69) 
Frail*time -3.87 (-4.99 - -2.75) -2.80 (-4.00 - -1.60) 
Age*time 0.48 (0.25 - 0.71) 0.57 (0.34 - 0.80) 
Age*age*time -0.01 (-0.01 - 0.00) -0.01 (-0.01 - 0.00) 
Female*time -2.84 (-3.11 - -2.57) -2.87 (-3.15 - -2.58) 
Antidepressant*time 
 
0.30 (-0.32 - 0.91) 
Antihypertensive*time -0.47 (-0.93 - -0.01) 
BMI*time 
 
0.31 (0.12 - 0.49) 
BMI*BMI*time 
 
-0.01 (-0.01 - 0.00) 
Past smoker*time 
 
-0.76 (-1.06 - -0.46) 
Current smoker*time -1.69 (-2.11 - -1.27) 
CES-D score*time 
 
-0.03 (-0.06 - -0.01) 
Diabetes*time 
 
-1.33 (-1.92 - -0.74) 
Stroke*time 
 
1.69 (0.30 - 3.08) 
Angina*time 
 
0.71 (-0.04 - 1.46) 
Heart attack*time 
 
0.67 (-0.11 - 1.45) 
Hypertension*time 
 
-1.26 (-1.58 - -0.94) 
Heart murmur*time 
 
-0.47 (-1.10 - 0.16) 
Interactions 20-30s    
Prefrail*time -0.25 (-0.55 - 0.05) -0.04 (-0.36 - 0.28) 
Frail*time -0.93 (-2.03 - 0.18) -0.61 (-1.80 - 0.58) 
Age*time 0.12 (-0.11 - 0.35) 0.09 (-0.13 - 0.32) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 1.94 (1.67 - 2.21) 1.80 (1.51 - 2.08) 
Antidepressant*time 
 
0.16 (-0.45 - 0.77) 
Antihypertensive*time 0.51 (0.06 - 0.97) 
BMI*time 
 
-0.15 (-0.34 - 0.03) 
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BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
-0.23 (-0.52 - 0.07) 
Current smoker*time -0.51 (-0.92 - -0.09) 
CES-D score*time 
 
-0.01 (-0.04 - 0.01) 
Diabetes*time 
 
-1.08 (-1.67 - -0.50) 
Stroke*time 
 
-0.12 (-1.49 - 1.25) 
Angina*time 
 
0.59 (-0.15 - 1.33) 
Heart attack*time 
 
-0.63 (-1.41 - 0.14) 
Hypertension*time 
 
0.64 (0.32 - 0.96) 
Heart murmur*time 
 
0.14 (-0.48 - 0.77) 
Interactions 30-110s    
Prefrail*time 0.10 (0.04 - 0.16) 0.07 (0.00 - 0.13) 
Frail*time 0.20 (-0.03 - 0.43) 0.10 (-0.15 - 0.35) 
Age*time 0.01 (-0.04 - 0.05) 0.01 (-0.04 - 0.05) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 0.06 (0.00 - 0.11) 0.04 (-0.01 - 0.10) 
Antidepressant*time 
 
0.08 (-0.05 - 0.21) 
Antihypertensive*time 0.04 (-0.05 - 0.14) 
BMI*time 
 
-0.03 (-0.07 - 0.01) 
BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
0.04 (-0.02 - 0.10) 
Current smoker*time 0.09 (0.01 - 0.18) 
CES-D score*time 
 
0.00 (0.00 - 0.01) 
Diabetes*time 
 
0.06 (-0.06 - 0.18) 
Stroke*time 
 
-0.07 (-0.36 - 0.21) 
Angina*time 
 
0.02 (-0.14 - 0.17) 
Heart attack*time 
 
-0.05 (-0.21 - 0.11) 
Hypertension*time 
 
0.02 (-0.05 - 0.08) 
Heart murmur*time 
 
0.13 (0.00 - 0.26) 
     
Intercept 65.22 (45.33 - 85.11) 53.15 (31.99 - 74.31) 
Random effects (identity matrix)   
Intercept variance 132.94 (127.04 - 139.11) 127.29 (121.58 - 133.27) 
AR1 Residuals by Frailty category   
variance     
Robust 27.24 (26.23 - 28.29) 27.01 (26.00 - 28.05) 
Prefrail 34.58 (32.49 - 36.80) 33.85 (31.80 - 36.02) 
Frail 43.00 (33.60 - 55.05) 44.42 (34.17 - 57.72) 
rho     
Robust 0.63 (0.62 - 0.65) 0.63 (0.62 - 0.65) 
Prefrail 0.67 (0.64 - 0.69) 0.66 (0.64 - 0.69) 
Frail 0.66 (0.57 - 0.74) 0.66 (0.56 - 0.75) 
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Table SA6: Mixed effects models for HR recovery 
Main effects Model 1 Model 2 
Period 1 10-20s -43.78 (-49.74 - -37.83) -27.96 (-34.38 - -21.54) 
Period 2 20-30s 18.36 (12.48 - 24.24) 18.46 (12.13 - 24.80) 
Period 3 30-110s 1.06 (-0.10 - 2.22) 1.44 (0.20 - 2.67) 
Prefrail 0.92 (0.18 - 1.67) 0.98 (0.22 - 1.74) 
Frail 2.09 (-0.32 - 4.50) 1.42 (-1.05 - 3.90) 
Age -0.66 (-1.22 - -0.10) -0.63 (-1.18 - -0.09) 
Age*age 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 
Female 0.29 (-0.39 - 0.97) -0.11 (-0.79 - 0.58) 
Antidepressant 
 
0.00 (-1.46 - 1.45) 
Antihypertensive 
 
-8.43 (-9.53 - -7.33) 
BMI 
 
-0.26 (-0.70 - 0.18) 
BMI*BMI 
 
0.01 (0.00 - 0.02) 
Past smoker 
 
-0.31 (-1.03 - 0.42) 
Current smoker 
 
0.83 (-0.18 - 1.83) 
CES-D score 
 
-0.03 (-0.09 - 0.03) 
Diabetes 
 
1.42 (0.03 - 2.81) 
Stroke 
 
-0.67 (-3.88 - 2.54) 
Angina 
 
-2.56 (-4.34 - -0.79) 
Heart attack 
 
-2.21 (-4.06 - -0.36) 
Hypertension 
 
0.14 (-0.63 - 0.91) 
Heart murmur 
 
-0.43 (-1.95 - 1.08) 
Interactions 10-20s    
Prefrail*time 1.03 (0.78 - 1.29) 0.71 (0.44 - 0.98) 
Frail*time 2.99 (2.22 - 3.76) 1.45 (0.61 - 2.29) 
Age*time 0.91 (0.72 - 1.09) 0.86 (0.67 - 1.05) 
Age*age*time 0.00 (-0.01 - 0.00) 0.00 (-0.01 - 0.00) 
Female*time -0.52 (-0.75 - -0.29) -0.67 (-0.91 - -0.43) 
Antidepressant*time 
 
1.52 (1.01 - 2.03) 
Antihypertensive*time 
 
0.38 (-0.01 - 0.76) 
BMI*time 
 
-0.96 (-1.11 - -0.80) 
BMI*BMI*time 
 
0.01 (0.01 - 0.02) 
Past smoker*time 
 
0.37 (0.12 - 0.62) 
Current smoker*time 
 
2.40 (2.05 - 2.75) 
CES-D score*time 
 
0.01 (-0.01 - 0.03) 
Diabetes*time 
 
1.01 (0.53 - 1.50) 
Stroke*time 
 
0.23 (-0.91 - 1.37) 
Angina*time 
 
0.88 (0.25 - 1.50) 
Heart attack*time 
 
0.61 (-0.04 - 1.26) 
Hypertension*time 
 
1.10 (0.83 - 1.37) 
Heart murmur*time 
 
-0.26 (-0.79 - 0.27) 
Interactions 20-30s    
Prefrail*time -0.04 (-0.29 - 0.21) 0.04 (-0.23 - 0.30) 
Frail*time -0.78 (-1.55 - -0.01) -0.73 (-1.56 - 0.10) 
Age*time -0.59 (-0.77 - -0.40) -0.58 (-0.76 - -0.39) 
Age*age*time 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 
Female*time 0.13 (-0.09 - 0.36) 0.13 (-0.11 - 0.37) 
Antidepressant*time 
 
0.24 (-0.27 - 0.74) 
Antihypertensive*time 
 
0.32 (-0.06 - 0.70) 
BMI*time 
 
0.02 (-0.13 - 0.17) 
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BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
0.03 (-0.22 - 0.27) 
Current smoker*time 
 
0.09 (-0.26 - 0.43) 
CES-D score*time 
 
-0.01 (-0.04 - 0.01) 
Diabetes*time 
 
0.41 (-0.07 - 0.90) 
Stroke*time 
 
0.08 (-1.04 - 1.21) 
Angina*time 
 
-0.68 (-1.29 - -0.06) 
Heart attack*time 
 
0.01 (-0.63 - 0.65) 
Hypertension*time 
 
-0.18 (-0.45 - 0.08) 
Heart murmur*time 
 
-0.54 (-1.06 - -0.02) 
Interactions 30-110s    
Prefrail*time -0.04 (-0.09 - 0.01) -0.02 (-0.07 - 0.03) 
Frail*time -0.14 (-0.30 - 0.02) -0.11 (-0.29 - 0.07) 
Age*time -0.02 (-0.05 - 0.02) -0.01 (-0.04 - 0.03) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 0.05 (0.00 - 0.09) 0.02 (-0.02 - 0.07) 
Antidepressant*time 
 
0.01 (-0.09 - 0.11) 
Antihypertensive*time 
 
-0.07 (-0.14 - 0.01) 
BMI*time 
 
-0.03 (-0.06 - 0.00) 
BMI*BMI*time 
 
0.00 (0.00 - 0.00) 
Past smoker*time 
 
-0.02 (-0.07 - 0.02) 
Current smoker*time 
 
-0.07 (-0.13 - 0.00) 
CES-D score*time 
 
0.00 (0.00 - 0.00) 
Diabetes*time 
 
-0.05 (-0.15 - 0.04) 
Stroke*time 
 
0.08 (-0.14 - 0.30) 
Angina*time 
 
-0.02 (-0.14 - 0.10) 
Heart attack*time 
 
0.06 (-0.07 - 0.18) 
Hypertension*time 
 
-0.03 (-0.08 - 0.03) 
Heart murmur*time 
 
-0.02 (-0.12 - 0.08) 
     
Intercept 108.79 (91.05 - 126.53) 105.66 (87.23 - 124.09) 
Random effects (identity matrix)     
Intercept variance 111.02 (106.20 - 116.05) 100.89 (96.46 - 105.52) 
AR1 Residuals by Frailty category     
variance     
Robust 18.43 (17.77 - 19.12) 17.76 (17.14 - 18.41) 
Prefrail 19.68 (18.71 - 20.69) 19.12 (18.19 - 20.09) 
Frail 21.05 (16.70 - 26.53) 21.92 (17.13 - 28.05) 
rho     
Robust 0.61 (0.60 - 0.63) 0.61 (0.59 - 0.62) 
Prefrail 0.59 (0.57 - 0.61) 0.58 (0.56 - 0.61) 
Frail 0.68 (0.59 - 0.75) 0.68 (0.59 - 0.76) 
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Table SA7: Mixed effects models for % BP & HR recovery by frailty criteria 
Main effects Systolic BP Diastolic BP Heart rate 
Period 1 10-20s -14.88 (-24.64 - -5.11) 6.27 (-4.77 - 17.30) -47.02 (-56.84 - -37.20) 
Period 2 20-30s 0.53 (-9.22 - 10.27) 3.03 (-7.92 - 13.98) 28.85 (19.13 - 38.57) 
Period 3 30-110s -0.59 (-2.94 - 1.76) -0.52 (-2.83 - 1.78) 2.12 (0.17 - 4.07) 
Slowness -0.72 (-2.12 - 0.68) 1.89 (0.45 - 3.32) -1.76 (-2.96 - -0.55) 
Low Activity 0.69 (-0.36 - 1.73) 0.64 (-0.43 - 1.71) 0.26 (-0.63 - 1.16) 
Weakness 0.09 (-1.23 - 1.40) -0.22 (-1.57 - 1.12) 0.29 (-0.84 - 1.41) 
Exhaustion 1.12 (-0.38 - 2.63) 0.73 (-0.81 - 2.27) -0.64 (-1.93 - 0.65) 
Weight loss 0.24 (-1.29 - 1.77) 0.30 (-1.27 - 1.87) 0.16 (-1.15 - 1.47) 
Age -0.58 (-1.16 - 0.01) -0.71 (-1.31 - -0.11) -0.59 (-1.10 - -0.09) 
Age*age 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 
Female -1.11 (-1.85 - -0.37) 0.79 (0.03 - 1.55) -1.29 (-1.92 - -0.65) 
Antidepressant -3.80 (-5.37 - -2.22) -2.47 (-4.08 - -0.86) -3.34 (-4.69 - -1.99) 
Antihypertensive -2.93 (-4.12 - -1.74) -2.84 (-4.06 - -1.62) -2.54 (-3.57 - -1.52) 
BMI 0.84 (0.37 - 1.32) 0.99 (0.51 - 1.48) 0.76 (0.35 - 1.16) 
BMI*BMI -0.01 (-0.02 - 0.00) -0.01 (-0.02 - 0.00) -0.01 (-0.02 - 0.00) 
Past smoker 0.45 (-0.33 - 1.23) 0.45 (-0.35 - 1.25) 0.00 (-0.67 - 0.68) 
Current smoker -0.03 (-1.12 - 1.05) 0.80 (-0.31 - 1.91) -2.75 (-3.69 - -1.82) 
CES-D score -0.02 (-0.09 - 0.05) 0.03 (-0.04 - 0.10) 0.01 (-0.05 - 0.07) 
Diabetes 1.50 (-0.01 - 3.00) 1.06 (-0.48 - 2.60) -3.20 (-4.50 - -1.91) 
Stroke -1.85 (-5.31 - 1.62) -3.21 (-6.76 - 0.34) -0.11 (-3.08 - 2.87) 
Angina -2.88 (-4.79 - -0.96) -3.85 (-5.81 - -1.90) -1.34 (-2.98 - 0.30) 
Heart attack 1.40 (-0.60 - 3.39) 0.61 (-1.43 - 2.65) -1.04 (-2.75 - 0.67) 
Hypertension 1.17 (0.33 - 2.00) 1.36 (0.51 - 2.21) -2.11 (-2.83 - -1.40) 
Heart murmur -0.17 (-1.80 - 1.47) -1.24 (-2.91 - 0.44) 0.45 (-0.95 - 1.86) 
Interactions 10-20s       
Slowness*time -2.33 (-3.02 - -1.64) -3.82 (-4.59 - -3.04) 3.26 (2.57 - 3.96) 
Low Activity*time -0.48 (-0.99 - 0.04) -0.56 (-1.14 - 0.02) 0.21 (-0.30 - 0.73) 
Weakness*time -0.41 (-1.05 - 0.24) -0.26 (-0.98 - 0.47) 0.53 (-0.12 - 1.18) 
Exhaustion*time -0.76 (-1.50 - -0.02) -0.62 (-1.45 - 0.22) 1.20 (0.46 - 1.95) 
Weight loss*time -0.61 (-1.37 - 0.14) -1.11 (-1.96 - -0.26) 0.05 (-0.71 - 0.80) 
Age*time 0.81 (0.52 - 1.10) 0.70 (0.37 - 1.02) 1.48 (1.19 - 1.77) 
Age*age*time -0.01 (-0.01 - -0.01) -0.01 (-0.01 - -0.01) -0.01 (-0.01 - -0.01) 
Female*time -1.65 (-2.01 - -1.28) -3.19 (-3.60 - -2.78) -0.87 (-1.24 - -0.50) 
Antidepressant*time -0.54 (-1.31 - 0.23) -0.04 (-0.92 - 0.83) 2.30 (1.53 - 3.08) 
Antihypertensive*time -0.02 (-0.60 - 0.57) 0.14 (-0.52 - 0.80) -0.14 (-0.73 - 0.45) 
BMI*time 1.00 (0.77 - 1.23) 0.39 (0.13 - 0.65) -1.53 (-1.77 - -1.30) 
BMI*BMI*time -0.01 (-0.02 - -0.01) -0.01 (-0.01 - 0.00) 0.02 (0.02 - 0.03) 
Past smoker*time -0.52 (-0.90 - -0.14) -0.94 (-1.38 - -0.51) 0.48 (0.09 - 0.86) 
Current smoker*time -2.02 (-2.55 - -1.49) -1.97 (-2.57 - -1.36) 3.84 (3.30 - 4.38) 
CES-D score*time -0.03 (-0.07 - 0.00) -0.07 (-0.10 - -0.03) 0.01 (-0.02 - 0.04) 
Diabetes*time -0.48 (-1.22 - 0.26) -1.37 (-2.21 - -0.54) 1.49 (0.75 - 2.23) 
Stroke*time 1.46 (-0.24 - 3.16) 3.59 (1.66 - 5.51) -0.06 (-1.77 - 1.65) 
Angina*time 1.55 (0.62 - 2.49) 1.86 (0.80 - 2.92) 1.24 (0.29 - 2.18) 
Heart attack*time 0.90 (-0.07 - 1.88) 2.05 (0.94 - 3.15) 1.04 (0.06 - 2.02) 
Hypertension*time -2.16 (-2.57 - -1.75) -2.36 (-2.82 - -1.89) 1.79 (1.38 - 2.20) 
Heart murmur*time 0.89 (0.09 - 1.69) -0.47 (-1.38 - 0.44) -0.50 (-1.30 - 0.31) 
Interactions 20-30s       
Slowness*time 0.96 (0.27 - 1.65) 0.70 (-0.07 - 1.47) -0.25 (-0.94 - 0.43) 
Low Activity*time -0.45 (-0.96 - 0.06) -0.64 (-1.21 - -0.06) 0.04 (-0.47 - 0.55) 
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Weakness*time 0.56 (-0.09 - 1.20) 0.66 (-0.07 - 1.38) -0.39 (-1.03 - 0.26) 
Exhaustion*time -0.89 (-1.63 - -0.16) -0.70 (-1.53 - 0.13) 0.47 (-0.26 - 1.21) 
Weight loss*time -0.74 (-1.49 - 0.01) -0.92 (-1.76 - -0.07) 0.15 (-0.60 - 0.90) 
Age*time 0.07 (-0.22 - 0.36) 0.19 (-0.13 - 0.51) -0.90 (-1.19 - -0.62) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 0.01 (0.00 - 0.01) 
Female*time 1.53 (1.16 - 1.89) 2.61 (2.20 - 3.02) 0.25 (-0.11 - 0.61) 
Antidepressant*time 0.94 (0.17 - 1.71) 0.18 (-0.68 - 1.05) 0.26 (-0.51 - 1.03) 
Antihypertensive*time 0.82 (0.24 - 1.41) 0.84 (0.18 - 1.49) 0.34 (-0.25 - 0.92) 
BMI*time -0.22 (-0.46 - 0.01) -0.38 (-0.64 - -0.12) 0.02 (-0.21 - 0.25) 
BMI*BMI*time 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.01) 0.00 (0.00 - 0.00) 
Past smoker*time -0.21 (-0.59 - 0.17) -0.33 (-0.76 - 0.10) -0.03 (-0.41 - 0.35) 
Current smoker*time 0.43 (-0.10 - 0.97) -0.57 (-1.17 - 0.03) 0.16 (-0.37 - 0.69) 
CES-D score*time 0.00 (-0.03 - 0.04) 0.00 (-0.04 - 0.04) -0.03 (-0.07 - 0.00) 
Diabetes*time -1.03 (-1.77 - -0.29) -1.10 (-1.93 - -0.27) 0.73 (-0.01 - 1.46) 
Stroke*time 0.48 (-1.22 - 2.18) -0.20 (-2.10 - 1.71) 0.17 (-1.52 - 1.86) 
Angina*time 0.82 (-0.12 - 1.76) 1.28 (0.22 - 2.33) -1.03 (-1.97 - -0.10) 
Heart attack*time -0.42 (-1.39 - 0.56) -0.50 (-1.60 - 0.60) -0.06 (-1.04 - 0.91) 
Hypertension*time 0.73 (0.33 - 1.14) 0.73 (0.27 - 1.19) -0.18 (-0.59 - 0.23) 
Heart murmur*time 0.15 (-0.65 - 0.95) 0.33 (-0.57 - 1.23) -0.78 (-1.58 - 0.02) 
Interactions 30-110s       
Slowness*time 0.22 (0.06 - 0.39) 0.11 (-0.05 - 0.27) -0.10 (-0.23 - 0.04) 
Low Activity*time 0.06 (-0.06 - 0.18) 0.05 (-0.07 - 0.17) 0.02 (-0.08 - 0.12) 
Weakness*time 0.05 (-0.11 - 0.20) 0.01 (-0.15 - 0.16) -0.02 (-0.15 - 0.11) 
Exhaustion*time 0.11 (-0.07 - 0.29) 0.12 (-0.05 - 0.30) -0.09 (-0.24 - 0.06) 
Weight loss*time 0.03 (-0.15 - 0.21) 0.05 (-0.13 - 0.23) -0.01 (-0.16 - 0.14) 
Age*time 0.03 (-0.04 - 0.10) 0.01 (-0.05 - 0.08) -0.01 (-0.06 - 0.05) 
Age*age*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Female*time 0.04 (-0.05 - 0.13) 0.07 (-0.02 - 0.15) 0.02 (-0.05 - 0.10) 
Antidepressant*time 0.14 (-0.04 - 0.33) 0.10 (-0.08 - 0.29) 0.02 (-0.13 - 0.18) 
Antihypertensive*time 0.00 (-0.14 - 0.15) 0.05 (-0.09 - 0.19) -0.10 (-0.21 - 0.02) 
BMI*time -0.09 (-0.14 - -0.03) -0.05 (-0.11 - 0.00) -0.04 (-0.09 - 0.00) 
BMI*BMI*time 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 0.00 (0.00 - 0.00) 
Past smoker*time 0.04 (-0.06 - 0.13) 0.05 (-0.04 - 0.14) -0.04 (-0.12 - 0.03) 
Current smoker*time 0.18 (0.05 - 0.30) 0.11 (-0.02 - 0.23) -0.12 (-0.22 - -0.01) 
CES-D score*time 0.00 (0.00 - 0.01) 0.01 (0.00 - 0.01) 0.00 (-0.01 - 0.01) 
Diabetes*time 0.12 (-0.06 - 0.30) 0.10 (-0.07 - 0.28) -0.08 (-0.22 - 0.07) 
Stroke*time -0.13 (-0.54 - 0.28) -0.21 (-0.61 - 0.19) 0.14 (-0.20 - 0.48) 
Angina*time 0.12 (-0.11 - 0.34) 0.05 (-0.17 - 0.27) -0.03 (-0.22 - 0.16) 
Heart attack*time 0.02 (-0.22 - 0.25) -0.06 (-0.29 - 0.17) 0.08 (-0.12 - 0.27) 
Hypertension*time 0.07 (-0.03 - 0.17) 0.04 (-0.06 - 0.13) -0.05 (-0.13 - 0.03) 
Heart murmur*time 0.12 (-0.08 - 0.31) 0.20 (0.01 - 0.39) -0.03 (-0.19 - 0.13) 
Intercept 83.69 (63.80 - 103.57) 78.80 (58.44 - 99.15) 142.09 (125.01 - 159.16) 
Random effects (identity matrix)     
Intercept variance 69.64 (64.89 - 74.73) 82.84 (78.37 - 87.57) 57.40 (54.32 - 60.66) 
AR1 Residuals        
variance       
  70.38 (67.05 - 73.87) 63.71 (61.56 - 65.93) 45.70 (44.29 - 47.16) 
rho       
  0.76 (0.75 - 0.77) 0.66 (0.65 - 0.67) 0.63 (0.61 - 0.64) 
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